177 related articles for article (PubMed ID: 3026016)
1. Clinical efficacy of sulbactam/ampicillin in pediatric infections caused by ampicillin-resistant or penicillin-resistant organisms.
Syriopoulou V; Bitsi M; Theodoridis C; Saroglou I; Krikos X; Tzanetou K
Rev Infect Dis; 1986; 8 Suppl 5():S630-3. PubMed ID: 3026016
[TBL] [Abstract][Full Text] [Related]
2. Activity of sulbactam/ampicillin in screening and discriminative animal models of infection.
English AR; Girard D; Cimochowski C; Faiella J; Retsema JA; Lynch JE
Rev Infect Dis; 1986; 8 Suppl 5():S535-42. PubMed ID: 3026002
[TBL] [Abstract][Full Text] [Related]
3. Sulbactam/ampicillin: in vitro spectrum, potency, and activity in models of acute infection.
Retsema JA; English AR; Girard A; Lynch JE; Anderson M; Brennan L; Cimochowski C; Faiella J; Norcia W; Sawyer P
Rev Infect Dis; 1986; 8 Suppl 5():S528-34. PubMed ID: 3026001
[TBL] [Abstract][Full Text] [Related]
4. [Basic and clinical studies on tazobactam/piperacillin in pediatric field].
Motohiro T; Nagai K; Yamada T; Oki S; Yamada T; Yoshinaga Y; Tsumura N; Oda K; Sakata Y; Kato H; Imai S; Morita J; Matsuo Y; Ikezawa S; Takahgashi K; Fukuda T; Yamashita Y; Aramaki M; Hayashi M; Yamakawa R; Ono-E ; Tananari Y; Tsutsumi T; Hoshuyama A; Aida K
Jpn J Antibiot; 1998 Jun; 51(6):413-31. PubMed ID: 9755831
[TBL] [Abstract][Full Text] [Related]
5. A randomized, double-blind comparison of sulbactam/ampicillin and clindamycin for the treatment of aerobic and aerobic-anaerobic infections.
Reinhardt JF; Johnston L; Ruane P; Johnson CC; Ingram-drake L; MacDonald K; Ward KW; Mathisen G; George WL; Finegold SM
Rev Infect Dis; 1986; 8 Suppl 5():S569-75. PubMed ID: 3026005
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of sequential treatment with parenteral sulbactam/ampicillin and oral sultamicillin for skeletal infections in children.
Aronoff SC; Scoles PV; Makley JT; Jacobs MR; Blumer JL; Kalamchi A
Rev Infect Dis; 1986; 8 Suppl 5():S639-43. PubMed ID: 3026018
[TBL] [Abstract][Full Text] [Related]
7. Sulbactam/ampicillin in the treatment of acute epiglottitis in children.
Wald E; Reilly JS; Bluestone CD; Chiponis D
Rev Infect Dis; 1986; 8 Suppl 5():S617-9. PubMed ID: 3026014
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of beta-lactamase-induced resistance in soft-tissue infections.
Nichols RL; Smith JW; Adinolfi MF; Galli R; Vivoda LM
Arch Surg; 1985 Jan; 120(1):36-42. PubMed ID: 2981523
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of sulbactam plus ampicillin in gynecologic infections.
Giamarellou H; Trouvas G; Avlami A; Aravantinos D; Daikos GK
Rev Infect Dis; 1986; 8 Suppl 5():S579-82. PubMed ID: 3026007
[TBL] [Abstract][Full Text] [Related]
10. A clinical evaluation of sulbactam/ampicillin in the treatment of pediatric infections.
Huang LM; Lee CY; Lee MJ; Hsu CY; Liu CC; Hong JY; Chen JM
Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi; 1989; 30(2):87-93. PubMed ID: 2637593
[TBL] [Abstract][Full Text] [Related]
11. Intravenous sulbactam/ampicillin in the treatment of pediatric infections.
Lee CY; Lin TY; Chu ML; Lee MJ; Hsu CY; Huang LM; Chen CM
Diagn Microbiol Infect Dis; 1989; 12(4 Suppl):179S-183S. PubMed ID: 2686918
[TBL] [Abstract][Full Text] [Related]
12. In vitro activity of aminopenicillins combined with sulbactam, clavulanic acid, or amdinocillin against bacteria isolated from patients with complicated urinary tract infections.
Naber KG; Wittenberger R
Rev Infect Dis; 1986; 8 Suppl 5():S604-8. PubMed ID: 3026011
[TBL] [Abstract][Full Text] [Related]
13. Clinical results of a multicenter study with sulbactam/ampicillin for the treatment of patients with lower respiratory and urinary tract infections.
De Simone C; Chiodo F; Delia S; Pastore G; Scalise G; Sorice F; Tonietti G; Zanussi C; Paoloni M; Gargiulo M
J Chemother; 1991 Oct; 3(5):321-7. PubMed ID: 1809811
[TBL] [Abstract][Full Text] [Related]
14. [Pharmacokinetic, bacteriological and clinical studies of sulbactam/ampicillin in pediatric patients].
Motohiro T; Sakata Y; Oda K; Aramaki M; Tanaka K; Koga T; Shimada Y; Fujimoto T; Yamashita F; Sakamoto H
Jpn J Antibiot; 1989 Mar; 42(3):773-90. PubMed ID: 2664252
[TBL] [Abstract][Full Text] [Related]
15. Clinical efficacy and safety of sulbactam/ampicillin in patients suffering from chronic liver disease.
Galante D; Esposito S; Barba D; Ruffilli MP
J Antimicrob Chemother; 1987 Apr; 19(4):527-32. PubMed ID: 3034850
[TBL] [Abstract][Full Text] [Related]
16. Treatment of infections caused by ampicillin-resistant pathogens with a combination of ampicillin and CP-45,899.
Plouffe JF
Antimicrob Agents Chemother; 1982 Mar; 21(3):519-20. PubMed ID: 6285812
[TBL] [Abstract][Full Text] [Related]
17. [Clinical experience with sulbactam/ampicillin in the pediatric field].
Sekiguchi T; Okamoto T; Ohara K; Kohzan S; Nishimori M; Miyazaki M
Jpn J Antibiot; 1989 Mar; 42(3):733-42. PubMed ID: 2746853
[TBL] [Abstract][Full Text] [Related]
18. Sulbactam/ampicillin vs. chloramphenicol/ampicillin for the treatment of meningitis in infants and children.
RodrÃguez WJ; Khan WN; Puig J; Feris J; Harmon S; Gold BG; Ahmad S
Rev Infect Dis; 1986; 8 Suppl 5():S620-9. PubMed ID: 3026015
[TBL] [Abstract][Full Text] [Related]
19. Sulbactam plus ampicillin: interim review of efficacy and safety for therapeutic and prophylactic use.
Lees L; Milson JA; Knirsch AK; Greenhalgh K
Rev Infect Dis; 1986; 8 Suppl 5():S644-50. PubMed ID: 3026019
[TBL] [Abstract][Full Text] [Related]
20. A randomized controlled trial of ampicillin plus sulbactam vs. gentamicin plus clindamycin in the treatment of intraabdominal infections: a preliminary report. Study Group of Intraabdominal Infections.
Rev Infect Dis; 1986; 8 Suppl 5():S583-8. PubMed ID: 2879345
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
